NEWS COMMENTARY

Merck Animal Health's acquisition of IdentiGEN indicates imminent system change for livestock production

Published:
August 06, 2020
Coverage:
Emerging Ecosystems in Agrifood and Health More...
Activities:
Acquisition
Average importance

IdentiGEN's DNA TraceBack combines livestock DNA and data analytics to increase the traceability of beef, seafood, pork, and poultry products. The deal closely follows Merck's acquisition of Quantified Ag and complements Merck's growing portfolio of animal health monitoring technologies. Moreover, the addition of IdentiGEN enables Merck to monitor livestock through the entire value chain, improve its position in animal tracking, and more effectively promote its portfolio of medicines, vaccines, and services to livestock producers. Clients, this move sets Merck up to dominate in the animal health space; invest or engage with technologies that collect animal data (related to health or location) to sustain market share, or risk falling behind.

For the original news article, click here .


Further Reading

Zoetis acquires Performance Livestock Analytics, deeming precision livestock farming a vital opportunity

News Commentary | April 13, 2020

Animal health company Zoetis is acquiring Performance Livestock Analytics to strengthen its position within the precision livestock farming (PLF) space. Performance Livestock Analytics develops a cloud‑based livestock management platform for beef cattle called Performance Beef and a complementary ... Not part of subscription

ThoughtWire raises $11.5 million to commercialize digital twins for hospitals, albeit ignoring the simulation capabilities of twins

News Commentary | August 21, 2020

ThoughtWire will use the funding to continue its development efforts and growth initiatives for digital twins in hospitals and buildings. The company has developed a twin platform that orchestrates real‑time data from people, workflows, and equipment to enable task automation and predictive ... Not part of subscription

Resilient Biotics' $7.1 million Series A highlights the value of applying bioinformatics with purpose

News Commentary | February 02, 2021

Co‑led by Berkeley Catalyst Fund and Fulcrum Global Capital, the round included participation from Elanco Animal Health, Innovation in Motion, and Viking Global Investors. Resilient Biotics develops a discovery platform to assess the respiratory commensal microbiome and identify potential ... Not part of subscription